モノクローン抗アセチルコリン受容体抗体は,実験的なミアステニアを引き起こす可能性があります
Nature
|August 14, 1980
まとめ
ミアステニア・グラビス (MG) は,アセチルコリン受容体 (AChR) を標的とした自己免疫疾患です. AChRに対する単一の抗体タイプは,ネズミの全スペクトルのMG症状を誘発することができます.
科学分野:
- 免疫学 免疫学とは
- 神経科学は神経科学である.
- 自己免疫疾患 自己免疫疾患
背景:
- ミアステニア・グラビス (MG) は,神経筋結節に影響する自己免疫疾患です.
- 免疫システムは,ニコチンアセチルコリン受容体 (AChR) を誤って攻撃する.
- MGのポリクローン抗セラは,ACHRの複数の決定因子を標的とした多様な抗体を含んでいます.
研究 の 目的:
- ミアステニア・グラビスの自己免疫反応を分析する.
- 単一の抗体種がMGを誘発できるかどうかを判断する.
- 自己免疫疾患における特定の抗体決定因子の役割を調査する.
主な方法:
- Torpedo AChR.に対するモノクローナル抗体を使用した.
- 正常なラットに静脈内注射されたモノクローナル抗AChR抗体.
- 急性筋縮症候群の誘導を観察した.
主要な成果:
- モノクローナル抗トルペドAChR抗体は,ネズミで急性ミアステニック症候群を誘発した.
- 抗体の単一の分子種が疾患の表れを引き起こすことが示されました.
- 特定の抗原的決定因子を標的とする抗体の病原性の可能性を強調した.
結論:
- アセチルコリン受容体の特定の決定因子を標的にする単一の抗体タイプは,マイアステニア・グラビスを引き起こすのに十分です.
- この発見は,自己免疫疾患の病原性の理解を簡素化する.
- モノクローナル抗体分析は,複雑な自己免疫反応の解剖のための強力なツールです.
関連する概念動画
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...